Advertisement

Topics

FDA Approves Treatment For Underlying Causes Of Cystic Fibrosis

08:53 EST 13 Feb 2018 | Pharmaceutical Processing

Symdeko, Vertex’s third medicine to treat the underlying cause of cystic fibrosis, will begin shipping to pharmacies this week, according to the company.
Contributed Author: 
Vertex Pharmaceuticals Incorporated

Original Article: FDA Approves Treatment For Underlying Causes Of Cystic Fibrosis

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Treatment For Underlying Causes Of Cystic Fibrosis"

Advertisement
Quick Search
Advertisement
Advertisement